| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/08/2008 | CA2667839A1 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 05/08/2008 | CA2667515A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
| 05/08/2008 | CA2667513A1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one |
| 05/08/2008 | CA2667511A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 05/08/2008 | CA2666750A1 Phenylpropionamide compounds and the use thereof |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918366A1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 05/07/2008 | EP1918299A1 Modulators of cell adhesion molecules and use thereof |
| 05/07/2008 | EP1918297A1 Neuronal differentiation-inducing peptide and use thereof |
| 05/07/2008 | EP1918292A1 Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 05/07/2008 | EP1918290A1 Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide |
| 05/07/2008 | EP1918286A1 Thiazolhydrazides for treatment of neurodegenerative diseases |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1917273A2 Apoe mimetic agents |
| 05/07/2008 | EP1917267A1 Crystal form of asenapine maleate |
| 05/07/2008 | EP1917265A1 HETEROARYL-SUBSTiTUTED DIAZATRICYCLOALKANES, METHODS FOR ITS PREPARATION AND USE THEREOF |
| 05/07/2008 | EP1917264A1 Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/07/2008 | EP1917261A1 Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine d3 receptor modulators |
| 05/07/2008 | EP1917256A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 05/07/2008 | EP1917251A2 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
| 05/07/2008 | EP1917247A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 05/07/2008 | EP1917245A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 05/07/2008 | EP1917244A2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 05/07/2008 | EP1917242A1 Azabicyclo [3.1.0]hexylphenyl derivatives as modulators of dopamine d3 receptors |
| 05/07/2008 | EP1917021A2 Methods for the treatment of anxiety and for identification of anxiolytic agents |
| 05/07/2008 | EP1917017A2 Treatment of amyotrophic lateral sclerosis with pyrimethamine and analogues 6 |
| 05/07/2008 | EP1917014A1 Neurorestoration with r(+) pramipexole |
| 05/07/2008 | EP1917009A2 Carbamate compounds for use in treating neurodegenerative disorders |
| 05/07/2008 | EP1917006A2 Use of inhibitors of n-methyl transferases for the therapy of parkinson's disease |
| 05/07/2008 | EP1592446B1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 05/07/2008 | EP1558600B1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/07/2008 | EP1539751B1 Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides |
| 05/07/2008 | EP1513588B1 Use of new etonogestrel esters |
| 05/07/2008 | EP1509216B1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 05/07/2008 | EP1485051B1 Method of administering buprenorphine to treat depression |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1385531B1 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 05/07/2008 | EP1383774B1 Dihydroimidazo¬4,5-e indole and 7h-pyrrolo¬3,2-f quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 05/07/2008 | EP1380593B1 Soluble rage protein |
| 05/07/2008 | EP1250325B1 Phenanthridine-n-oxides |
| 05/07/2008 | EP1141306B1 Streptococcus antigens |
| 05/07/2008 | EP1137810B1 Peptide screening assay for the determination of gamma-secretase activity |
| 05/07/2008 | EP1137666B1 Glp-1 analogues |
| 05/07/2008 | EP1059929B1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 05/07/2008 | EP1049707B1 Ustilipides, method for the production and the use thereof |
| 05/07/2008 | CN101175755A N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 05/07/2008 | CN101175754A Novel tetrahydro-1h-pyrido [4,3-b] indole derivatives as cb1' receptor ligands |
| 05/07/2008 | CN101175751A Crystal of indole derivative having piperidine ring and process for production thereof |
| 05/07/2008 | CN101175740A Dihydrobenzofuran derivatives and uses thereof |
| 05/07/2008 | CN101175737A Pro-drugs of N-thiazol-2yl-benzamide derivatives |
| 05/07/2008 | CN101173295A Compositions and methods for identifying antigens which elicit an immune response |
| 05/07/2008 | CN101173279A SCIRR69 gene, regulation BDNF transcription and application in biomedicine research, biological therapeutic research and invention |
| 05/07/2008 | CN101172967A Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide |
| 05/07/2008 | CN101172137A Method for high effectively extracting pseudo-purslane saponin by using cavitated suspension extraction and stripping apparatus |
| 05/07/2008 | CN101172124A Novel uses of pennycress, pharmaceutical composition containing the pennycress and and preparation method thereof |
| 05/07/2008 | CN101172123A Uses of boraginaceae Cynoglossum L. in preparing medicament for treating neurous system disease |
| 05/07/2008 | CN101172105A Use of levetiracetam in preparing intelligence benefiting medicament |
| 05/07/2008 | CN101172103A Medicament for treating multiple diseases such as climacteric syndrome and osteoporosis of women |
| 05/07/2008 | CN101171927A Choline-silicic acid complex with osmolytes and divalent trace elements |
| 05/07/2008 | CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 05/07/2008 | CN100386328C Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 05/07/2008 | CN100386326C 1-methylolimidazole [1,2-alpha] quinoxaline compound and its application |
| 05/07/2008 | CN100386314C Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof |
| 05/07/2008 | CN100386113C Injectio of brain protein hydrolysate and its preparing process |
| 05/07/2008 | CN100386093C Medicine composition for treating cold and upper respiratory tract infection, preparation method and purpose thereof |
| 05/07/2008 | CN100386082C Oryzanol composition and its preparation method |
| 05/07/2008 | CN100386078C Nimodipine emulsion injection liquid and method for preparing the same |
| 05/07/2008 | CN100386070C Pharmaceutical formulation comprising melatonin |
| 05/06/2008 | US7368563 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, alzheimer's, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368562 Treatment of atherosclerosis, hypercholesterolemia diabetes, obesity, stroke, demyelination and lowering plasma levels of sterols |
| 05/06/2008 | US7368553 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 05/06/2008 | US7368472 1,2,4-Triaminobenzene derivatives useful for treating disorders of the central nervous system |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | US7368449 2-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists |
| 05/06/2008 | US7368448 2-(arylalkoxy)-1-phenylethylamine derivatives as NK1 antagonist and serotonin reuptake inhibitors |
| 05/06/2008 | US7368427 GLP-1 analogues |
| 05/06/2008 | US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2377803C Phenyl sulfamate derivatives |
| 05/06/2008 | CA2322229C Compositions comprising heparin and soluble tnf receptors for inhibition of tnf activity |
| 05/02/2008 | WO2008052183A2 Therapeutic compositions and methods of treatment with capsianoside-type compounds |
| 05/02/2008 | WO2008052139A2 Ultra low dose doxepin and methods of using the same to treat sleep disorders |
| 05/02/2008 | WO2008052088A1 Chromane derivatives, synthesis thereof, and intermediates thereto |
| 05/02/2008 | WO2008052087A1 Chromane derivatives and uses thereof |
| 05/02/2008 | WO2008052086A1 Benzodioxane derivatives and uses thereof |
| 05/02/2008 | WO2008052078A2 Benzoxathiine and benzoxathiole derivatives and uses thereof |
| 05/02/2008 | WO2008052075A2 Benzoxazine derivatives and uses thereof |
| 05/02/2008 | WO2008052044A2 Use of derivatives of propofol for treating diseases associated with oxidative stress |
| 05/02/2008 | WO2008051760A2 Combination therapy for the treatment of pain |
| 05/02/2008 | WO2008051017A1 A cleavage agent selectively acting on soluble assembly of amyloidogenic peptide or protein |
| 05/02/2008 | WO2008050916A1 Oleanane triterpene saponin compounds which are effective on treatment of dementia and mild cognitive impairment(mci), and improvement of cognitive function |
| 05/02/2008 | WO2008050866A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
| 05/02/2008 | WO2008050754A1 Intracerebral oxidation inhibitor and use thereof |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008050698A2 Agent for prophylaxis or treatment of alcohol dependence or drug dependence |